1-2 of 2
Jill Reckless
Close
Save search
Sort by
Journal Articles

Subcutaneous Marzeptacog Alfa (Activated) Versus Intravenous rFVIIa for Treatment of Episodic Bleeding in FVIII Deficient Hemophilia a Rats

Free
Tom Knudsen, Peter Johansen, Jill Reckless, Shraddha Desai, Grant E. Blouse
Journal: Blood
Blood (2021) 138 (Supplement 1): 3181.
https://doi.org/10.1182/blood-2021-151284
Published: 2021
Journal Articles

Fast Onset of Action of Subcutaneously Administered Marzeptacog Alfa (Activated) Supports on-Demand Treatment in Hemophilia a Mice

Free
Frank Del Greco, MBA, Linda Neuman, MD, Howard Levy, PhD MBBChir, Jill Reckless, Tom Knudsen, PhD DVM, Grant E. Blouse, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2420.
https://doi.org/10.1182/blood-2019-128971
Published: 2019